NasdaqGS:VTRSPharmaceuticals
Viatris (VTRS) Heavy FY 2025 Losses Keep Bullish Turnaround Narratives Under Pressure
Viatris (VTRS) has just wrapped up FY 2025 with Q4 revenue of US$3,703.6 million and a basic EPS loss of US$0.30, alongside a Q4 net loss of US$340.1 million, putting the focus squarely on how profit trends are evolving. Over recent periods, the company has seen quarterly revenue move between US$3,254.3 million and US$3,759.9 million, while basic EPS has ranged from a loss of US$2.55 to a small profit of US$0.08. This gives investors a clearer view of how earnings pressure has been affecting...